ResMed (RMD) Competitors $278.48 +1.84 (+0.66%) Closing price 10/3/2025 03:59 PM EasternExtended Trading$278.58 +0.10 (+0.04%) As of 10/3/2025 05:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RMD vs. MEDP, EHC, HIMS, ISRG, BSX, SYK, MDT, BDX, IDXX, and EWShould you be buying ResMed stock or one of its competitors? The main competitors of ResMed include Medpace (MEDP), Encompass Health (EHC), Hims & Hers Health (HIMS), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), IDEXX Laboratories (IDXX), and Edwards Lifesciences (EW). These companies are all part of the "medical" sector. ResMed vs. Its Competitors Medpace Encompass Health Hims & Hers Health Intuitive Surgical Boston Scientific Stryker Medtronic Becton, Dickinson and Company IDEXX Laboratories Edwards Lifesciences ResMed (NYSE:RMD) and Medpace (NASDAQ:MEDP) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, media sentiment, earnings, risk, dividends, profitability and institutional ownership. Do insiders & institutionals hold more shares of RMD or MEDP? 55.0% of ResMed shares are owned by institutional investors. Comparatively, 78.0% of Medpace shares are owned by institutional investors. 0.7% of ResMed shares are owned by insiders. Comparatively, 20.3% of Medpace shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is RMD or MEDP more profitable? ResMed has a net margin of 27.22% compared to Medpace's net margin of 18.74%. Medpace's return on equity of 67.66% beat ResMed's return on equity.Company Net Margins Return on Equity Return on Assets ResMed27.22% 25.62% 18.69% Medpace 18.74%67.66%21.86% Do analysts recommend RMD or MEDP? ResMed currently has a consensus price target of $294.20, suggesting a potential upside of 5.65%. Medpace has a consensus price target of $422.27, suggesting a potential downside of 20.70%. Given ResMed's stronger consensus rating and higher probable upside, analysts plainly believe ResMed is more favorable than Medpace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ResMed 0 Sell rating(s) 3 Hold rating(s) 10 Buy rating(s) 2 Strong Buy rating(s) 2.93Medpace 3 Sell rating(s) 12 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more risk & volatility, RMD or MEDP? ResMed has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500. Comparatively, Medpace has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500. Which has preferable earnings and valuation, RMD or MEDP? ResMed has higher revenue and earnings than Medpace. ResMed is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioResMed$5.15B7.90$1.40B$9.5129.28Medpace$2.11B7.09$404.39M$13.4539.59 Does the media prefer RMD or MEDP? In the previous week, ResMed had 3 more articles in the media than Medpace. MarketBeat recorded 17 mentions for ResMed and 14 mentions for Medpace. ResMed's average media sentiment score of 1.33 beat Medpace's score of 1.12 indicating that ResMed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ResMed 12 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Medpace 9 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryResMed beats Medpace on 10 of the 17 factors compared between the two stocks. Get ResMed News Delivered to You Automatically Sign up to receive the latest news and ratings for RMD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RMD vs. The Competition Export to ExcelMetricResMedMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$40.66B$10.99B$6.12B$21.82BDividend Yield0.86%1.87%5.65%3.54%P/E Ratio29.1722.1186.9629.82Price / Sales7.9027.54605.4267.04Price / Cash24.8725.0337.9024.90Price / Book6.843.4912.554.60Net Income$1.40B$212.45M$3.31B$1.00B7 Day Performance2.93%5.11%4.28%2.07%1 Month Performance0.52%1.56%6.90%3.33%1 Year Performance19.02%-7.70%70.54%13.11% ResMed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RMDResMed4.5971 of 5 stars$278.48+0.7%$294.20+5.6%+19.0%$40.66B$5.15B29.2810,600Positive NewsMEDPMedpace4.2694 of 5 stars$500.76+0.8%$422.27-15.7%+55.2%$14.07B$2.11B37.235,900News CoveragePositive NewsEHCEncompass Health4.8826 of 5 stars$125.83-0.7%$138.43+10.0%+30.3%$12.67B$5.37B24.6240,000News CoverageAnalyst ForecastHIMSHims & Hers Health3.5246 of 5 stars$59.06+1.1%$38.92-34.1%+198.0%$13.35B$1.48B73.831,637Insider TradeISRGIntuitive Surgical4.9542 of 5 stars$439.22-0.4%$595.95+35.7%-6.1%$157.45B$8.35B61.2615,638Trending NewsAnalyst ForecastBSXBoston Scientific4.922 of 5 stars$96.89-1.3%$118.38+22.2%+15.1%$143.57B$16.75B57.6753,000Trending NewsAnalyst ForecastInsider TradeAnalyst RevisionSYKStryker4.9706 of 5 stars$369.02flat$430.33+16.6%+5.5%$141.08B$22.60B48.8853,000Positive NewsEx-DividendMDTMedtronic4.8462 of 5 stars$94.00-0.2%$102.27+8.8%+10.6%$120.57B$33.54B25.8995,000News CoveragePositive NewsAnalyst ForecastBDXBecton, Dickinson and Company4.9355 of 5 stars$183.85-0.4%$213.09+15.9%-18.7%$52.70B$20.18B33.0774,000Positive NewsIDXXIDEXX Laboratories4.2636 of 5 stars$630.56-0.3%$649.44+3.0%+32.1%$50.44B$3.90B52.5011,000Positive NewsAnalyst ForecastEWEdwards Lifesciences4.8233 of 5 stars$77.25+1.3%$86.61+12.1%+17.6%$45.35B$5.44B11.1115,800Positive NewsShort Interest ↓ Related Companies and Tools Related Companies Medpace Competitors Encompass Health Competitors Hims & Hers Health Competitors Intuitive Surgical Competitors Boston Scientific Competitors Stryker Competitors Medtronic Competitors Becton, Dickinson and Company Competitors IDEXX Laboratories Competitors Edwards Lifesciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:RMD) was last updated on 10/5/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ResMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ResMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RMD Stock Alerts